Login

Sommet BFM patrimoine/CNCGP – Gay-Lussac Gestion | Louis de FELS, MD, Gay-Lussac Gestion SAAS OF 30 JUN 2023 00:10:00

Share On Facebook Share On Twitter

Louis De FELS is the MD of Gay-Lussac Gestion

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Solving the Remote Production Puzzle | Carleton Mickey Miller, CEO, Vislink Technologies IncVISL:NAQ
00:10:00
Adapting Strategies: Market Lessons and Future Outlooks | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Embracing Opportunities and Innovation in the Natural Gas Industry | Suzanne Sitherwood, CEO , Spire Inc.
00:00:00
Interviews Jens Lindberg, CEO Medivir at the Swiss Nordic Bio conference in Zürich, Switzerland - Jens Lindberg, CEO, Medivir
00:10:00
Archer Materials successfully fabricates nanosize biosensor components for its biochip | Dag Skindlo, CEO, Archer LtdARCH:OSL
00:10:00
Larry Fink's Vision for Economic Resilience and Hope | Larry Fink, CEO, BlackRock Inc.
00:10:00
Unlocking Potential: Royal Road Minerals' Path to Resource Expansion in Latin America
00:10:00
Pnvestment firm committed to helping create incredible technology companies|Wilder Ramsey,Partner & Co-Founder,Toba Capital
00:10:00
Special Needs Planning: Navigating the Future with a Special Needs Trust | Jennifer Barry, CFP® at Connecticut Wealth Management
00:10:00
driven to push humanity forward|Aneel Ranadive,Managing Partner,Soma Capital
00:10:00
WANdisco's partnership with IBM uniquely enables the active replication of data across hybrid, cloud, and on-premises environments.|David Richards, CEO of WANdisco PLC
00:10:00
Delivering Excellence in Aerospace & Defense Investment Banking

© 2026 Nehu